Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-160,700
Closed -$16M 102
2019
Q3
$16M Sell
160,700
-1,600
-1% -$152K 1.44% 32
2019
Q2
$15M Hold
162,300
1.32% 37
2019
Q1
$15.3M Buy
162,300
+1,200
+0.7% +$105K 1.34% 36
2018
Q4
$10.3M Sell
161,100
-1,800
-1% -$133K 1.02% 46
2018
Q3
$14.6M Sell
162,900
-8,650
-5% -$764K 1.16% 41
2018
Q2
$13.6M Sell
171,550
-11,800
-6% -$980K 1.15% 42
2018
Q1
$16.4M Sell
183,350
-1,550
-0.8% -$149K 1.28% 39
2017
Q4
$19.3M Sell
184,900
-4,400
-2% -$496K 1.44% 31
2017
Q3
$27.6M Sell
189,300
-1,650
-0.9% -$225K 2.14% 9
2017
Q2
$24.8M Sell
190,950
-3,150
-2% -$386K 1.98% 13
2017
Q1
$24.2M Sell
194,100
-4,600
-2% -$550K 1.93% 17
2016
Q4
$23M Sell
198,700
-27,566
-12% -$3.07M 1.75% 25
2016
Q3
$23.7M Sell
226,266
-32,200
-12% -$3.48M 1.51% 31
2016
Q2
$25.5M Sell
258,466
-49,900
-16% -$5.16M 1.09% 43
2016
Q1
$30.9M Sell
308,366
-36,500
-11% -$3.76M 1.13% 41
2015
Q4
$41.3M Sell
344,866
-11,000
-3% -$1.27M 1.31% 35
2015
Q3
$38.5M Sell
355,866
-11,600
-3% -$1.44M 1.25% 39
2015
Q2
$42.5M Sell
367,466
-26,898
-7% -$3.08M 1.18% 40
2015
Q1
$45.5M Sell
394,364
-18,748
-5% -$2.24M 1.19% 39
2014
Q4
$46.2M Sell
413,112
-4,260
-1% -$449K 1.11% 40
2014
Q3
$39.6M Sell
417,372
-7,100
-2% -$641K 0.91% 46
2014
Q2
$36.5M Sell
424,472
-19,620
-4% -$1.49M 0.77% 50
2014
Q1
$31M Sell
444,092
-27,342
-6% -$2.17M 0.67% 50
2013
Q4
$39.8M Sell
471,434
-22,732
-5% -$1.8M 0.78% 47
2013
Q3
$38.1M Sell
494,166
-12,800
-3% -$897K 0.65% 52
2013
Q2
$29.7M Buy
+506,966
New +$30.5M 0.5% 63

Other funds holding CELG

CS McKee's CELG Position: Q4 2019 in Review

CS McKee sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 160,700 shares — an estimated $16M sold.

CS McKee first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $46.2M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • CS McKee reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • CS McKee sold 160,700 Celgene Corp shares in Q4 2019, an estimated $16M.
  • CS McKee first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • CS McKee's Celgene Corp position peaked at $46.2M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on CS McKee's 13F filing for Q4 2019, filed 14 Feb 2020.